Sequestosome 1 (SQSTM1/p62) is a multifunctional protein involved in signal transduction, protein degradation and cell transformation. Hypoxia is a common feature of solid tumours that promotes cancer progression. Here, we report that p62 is downregulated in hypoxia in carcinoma cells and that the expression is rapidly restored in response to reoxygenation. The hypoxic p62 downregulation did not occur at the mRNA level and was independent of the hypoxic signal mediators hypoxiainducible factor (HIF) and von Hippel-Lindau tumour suppressor protein as well as the activity of HIF-prolyl hydroxylases and was not mediated by proteosomal destruction. Autophagy was activated in hypoxia and was required for p62 degradation. The hypoxic degradation of p62 was blocked by autophagy inhibitors as well as by the attenuation of Atg8/LC3 expression. Downregulation of p62 was required for hypoxic extracellular regulated kinase (ERK)-1/2 phosphorylation. Attenuation of p62 in normoxia activated and forced expression of p62 in hypoxia blocked the activation of ERK-1/2. The results demonstrate that hypoxic activation of autophagy induces clearance of p62 protein and implies a role for p62 in the regulation of hypoxic cancer cell survival responses.
Introduction
Hypoxia forms a key component of many pathological conditions such as cardiovascular and inflammatory diseases as well as solid tumours due to decreased or aberrant blood flow (Pugh and Ratcliffe, 2003; Semenza, 2003) . Hypoxia and, in some cases, the subsequent reoxygenation pose considerable stress to cells. Hypoxia directly impairs energy production and, hence, cell viability. On the other hand, excessive oxygen is highly toxic through the generation of reactive oxygen species, which damage proteins, lipids as well as genetic material (Koumenis and Wouters, 2006; Liu et al., 2006; Thuerauf et al., 2006) .
Autophagy is a tightly controlled process in which parts of the cytoplasm are sequestered in doublemembrane autophagosome vesicles. These fuse with lysosomes forming autolysosomes, where the contents of the vesicle are degraded (Levine and Kroemer, 2008; Mizushima et al., 2008) . Long-lived proteins and cellular organelles are degraded by autophagy to recycle macromolecules (Paludan et al., 2005) . Autophagy functions to maintain cellular homoeostasis and facilitate adaptation to adverse conditions. It controls cell survival, differentiation and growth as well as cellular defence and may have either protective or deathpromoting functions. At the early stages of tumour development, autophagy restricts growth. In contrast, at the more advanced stages, cancer cells may exploit autophagy as a tumour promoter (Kondo et al., 2005) .
Autophagy is activated in response to prolonged hypoxia or severe ischaemia followed by reoxygenation (Scherz-Shouval et al., 2007; Tracy et al., 2007; Zhang et al., 2008) . Oxidative stress induced by hypoxia or reoxygenation may trigger autophagy to remove nonfunctional cellular structures, such as damaged mitochondria and proteins, to prevent further damage. Autophagy may also postpone the onset of cell death by maintaining homoeostasis through catabolic energy production. However, if severe reperfusion deficits are not corrected, a sustained high level of autophagic activity eventually leads to cell demise and severe tissue damage (Adhami et al., 2006; Scherz-Shouval et al., 2007) .
Sequestosome 1 (SQSTM1/p62, herein designated as p62) is a multifunctional signal adaptor protein controlling a variety of cellular functions. p62 regulates bone remodelling by controlling osteoclastogenesis, inflammatory reactions through T-cell differentiation and attenuates adipocyte differentiation by limiting mitogenic signal transduction (Duran et al., 2004; Martin et al., 2006; Rodriguez et al., 2006) . It regulates nerve growth factor receptor internalization and protein localization and may be required for Ras-induced cell transformation by regulating the NF-kB pathway (Geetha et al., 2005; Duran et al., 2008) . Importantly, p62 may regulate oxygen consumption and downregulate the phosphorylation of extracellular regulated kinases (ERK-1/2; Rodriguez et al., 2006) . p62 transports polyubiquitinated proteins to degradation by proteasome and autophagy systems and is a common component of protein aggregates in neurodegenerative and liver diseases (Kuusisto et al., 2001a; Zatloukal et al., 2002; Seibenhener et al., 2004) . The expression of p62 is induced by the aggregation of unfolded proteins. This aggregation may be launched by changes in cellular redox state, for example during oxidative stress or the inhibition of proteasomal activity by overload of ubiquitin-proteasome system (UPS) (Kuusisto et al., 2001b; Thompson et al., 2003; Nakaso et al., 2004) . Autophagy may be involved in the clearance of such protein aggregates, with p62 playing an active role in the process. The p62 protein binds directly both to a central component of the autophagy machinery, light-chain 3 (LC3), and to ubiquitylated proteins. Thereby, p62 may mediate the recognition of protein aggregates for autophagic clearance (Bjorkoy et al., 2005; Pankiv et al., 2007) . In line with this, proper turnover of p62 by autophagy is required to avoid excessive aggregate formation (Komatsu et al., 2007) . Cells sense variations in oxygen level through a family of dioxygenase enzymes that use molecular oxygen as a co-substrate. These are termed prolyl hydroxylase domain proteins (PHDs), hypoxia-inducible factor (HIF) prolyl hydroxylases (HPHs) or Egl-9 homologues (Bruick and McKnight, 2001; Epstein et al., 2001) . Three known PHD isoforms (PHD1-3) hydroxylate the a-subunits of HIF-1 and -2 under normoxic conditions at two proline residues (Pro402 and -564) (Ivan et al., 2001; Jaakkola et al., 2001; Masson et al., 2004) . The hydroxylated HIF-1a is recognized by the von HippelLindau tumour suppressor protein (pVHL), leading to ubiquitination and proteosomal destruction of HIF-1a. Under restricted oxygen availability the PHD activity decreases, HIF-1a degradation attenuates and, together with HIF-1b, binds to DNA-activating transcription of an array of genes involved in hypoxic adaptation (Schofield and Ratcliffe, 2004; Kaelin, 2005) .
Besides activating transcription hypoxia, it also regulates protein translation and signal transduction through the mitogenic Ras/ERK and PI3K/Akt pathways that enhance cell survival under hypoxic stress (Minet et al., 2000; Kwon et al., 2006) . Here, we show that acute hypoxia-activated autophagy downregulates p62 expression in an HIF-independent manner in cancer cells. Furthermore, our data indicate that the downregulation of p62 protein level has a role in controlling hypoxia-induced Ras/ERK signalling.
Results
Oxygen availability regulates SQSTM1/p62 protein levels To study whether p62 protein levels are affected by lowered oxygen availability, HeLa cells were exposed to normoxia (21% O 2 ) and hypoxia (1% O 2 ) for 24 and 48 h followed by p62 protein expression measurement by western blot analysis. After 24 h hypoxia, the p62 protein level was markedly reduced and was more prominent after 48 h (Figure 1a ). To confirm that the hypoxic disappearance of p62 does not result from the aggregation of p62 into non-soluble fraction, we performed experiments using two vigorous extraction conditions. The use of Triton/SDS extraction with mercaptoethanol ( Figure 1a ) and 9 M urea extraction (Supplementary Figure 1) demonstrated a similar hypoxic disappearance of p62. To investigate whether the response is restricted to HeLa cells, we used several other human cell lines (immortalized HaCaT keratinocytes, embryonic kidney cells HEK293, osteosarcoma U2OS cells and SCC9 head and neck squamous carcinoma cells) to investigate the hypoxic p62 expression. The cells were exposed to normoxia or hypoxia for 48 h. In all cell lines studied, the p62 level was strongly reduced in response to hypoxia, demonstrating a widespread effect of hypoxia on p62 abundance (Figure 1b) .
Reoxygenation reverses most hypoxic responses such as HIF-a expression. To investigate whether reoxygenation restores the p62 expression, HeLa cells were exposed to a 24-h hypoxia and subsequently reoxygenated for 2, 4, 6 and 8 h. At 2 h post-reoxygenation, the p62 protein levels markedly increased compared with hypoxia. Between 4 and 6 h after reoxygenation, the p62 level rose close to normoxic levels, indicating fast recovery in response to oxygen increase (Figures 1c and d) .
In addition to its localization in autophagic vesicles, endogenous p62 forms distinctive cytoplasmic bodies of varying size and localization (Bjorkoy et al., 2005; Wooten et al., 2006) . We studied whether hypoxia or reoxygenation has an effect on the distribution of the p62-positive bodies. In normoxic conditions, p62 was localized mainly to the cytoplasm and showed a punctuated staining pattern. After a 24-h hypoxia, the p62 staining was significantly reduced compared with the normoxic control. Localization of the remnant p62 resembled that seen in normoxia. After an 8-h reoxygenation, the p62 expression reappeared. Interestingly, more p62 bodies appeared and these were located more prominently in the perinuclear region (Figure 1e) . Partially, the p62 bodies co-localized with golgin-97, indicating new protein synthesis in the Golgi apparatus (Supplementary Figure 1) . Supporting de novo p62 protein synthesis upon reoxygenation, the blockade of protein translation by cycloheximide prevented the reappearance of p62 (Figure 1f ).
Inhibition of HPH activity does not mimic hypoxic downregulation of p62 A large part of the hypoxic responses are mediated by the HIF pathway that can be mimicked by blocking HPH (PHD) activity. To study whether the inhibition of PHD activity induces p62 downregulation, we used two well-characterized hydroxylase inhibitors, dimethyloxaloylglycine (DMOG) and desferrioxamine (DFO). HeLa cells were challenged with hypoxia or with the prolyl hydroxylase inhibitors for various times up to 48 h followed by p62 expression analysis by western blot. Hypoxia markedly reduced p62 expression at the 8-h time point, and the disappearance of p62 was nearly complete after 16 h hypoxia ( Figure 2a ). In contrast, the inhibition of the prolyl hydroxylase activity by DMOG, performed in parallel with the hypoxic experiment, was strikingly less efficient in downregulating p62 expression ( Figure 2b ). After 16-24 h of DMOG exposure, negligible p62 downregulation occurred, although HIF-1a was stabilized as expected. However, after a 48-h DMOG treatment, a decrease in p62 expression was observed. Similarly to DMOG, DFO did not decrease p62 after a 24-h treatment, but a reduction was seen after 48 h ( Figure 2c ).
Next, we performed attenuation of each individual PHD isoform by previously validated siRNA oligonucleotides (Berra et al., 2003; Jokilehto et al., 2006) . In line with the chemical hydroxylase activity inhibition, depletion of PHD1, PHD2 or PHD3 expression with siRNA did not prevent the 24-h hypoxic downregulation of p62 as compared with control siRNA (scr). Noticeably, the depletion of any PHD did not cause a decrease in the normoxic p62 expression (Figure 2d ). The data indicated that the acute (24 h) hypoxic p62 downregulation is not mimicked by the inhibition of HPHs.
Hypoxic downregulation of p62 is HIF and VHL independent To further study the role of HIF-1a in the hypoxic regulation of p62, we used siRNA to downregulate HIF-1a in HeLa cells. Cells were transfected with a previously validated HIF-1a siRNA (Berra et al., 2003) , followed by a hypoxic exposure for 24 h. In keeping with the lack of effect with the inhibition of PHD activity, HIF-1a siRNA did not have any significant effect on the hypoxic downregulation of p62 as compared with the control siRNA (Figure 3a) . HIF-2a expression is more restricted across tissues but is induced by hypoxia in HeLa cells. We further attenuated HIF-2a expression by siRNA. Similarly to the attenuation of HIF-1a, p62 was efficiently downregulated in hypoxia upon HIF-2a siRNA exposure (Figure 3b) . Moreover, the inhibition of neither HIF-1a nor HIF-2a affected the reappearance of p62 upon reoxygenation (Supplementary Figure 1) . pVHL is required for normal hypoxic HIF regulation. The human renal clear cell carcinoma cell line, RCC4, lacks a functional pVHL and demonstrates constitutive HIF-1a expression. To study the role of pVHL in p62 regulation, we used RCC4 cells stably transfected to express an empty vector (RCCwt) or a wild-type pVHL (RCC þ pVHL). Supporting the lack of effect on p62 expression with HIF-1a siRNA, both of these cell lines efficiently downregulated p62 expression in response to hypoxia. p62 expression was decreased by hypoxia in the RCC þ pVHL line, which showed normal HIF-1a regulation and to a similar extent in the RCCwt line, which demonstrated HIF-1a expression both in normoxia and hypoxia (Figure 3b ). Besides further validating the HIF-1a-independent p62 downregulation, this indicated that the hypoxic p62 decrease is also pVHL independent.
To elucidate whether HIF-independent transcriptional regulation of p62 expression was involved in hypoxia, we studied the p62 mRNA expression using quantitative real-time PCR analysis (TaqMan) from HeLa cells exposed to normoxia or hypoxia for 24 h (Figure 3c) . In contrast to a well-characterized hypoxiaresponsive gene, Glut-1, that was strongly induced by hypoxia, p62 mRNA expression did not show significant change upon hypoxic exposure. However, p62 protein levels were strongly reduced in experiments performed in parallel (Figure 3c , inset). The data indicated that p62 is not regulated at the mRNA level in hypoxia.
Hypoxia downregulates p62 through autophagy
To investigate whether hypoxia causes a block in p62 translation or an increased post-translational removal, we analysed the stability of p62 protein. Protein translation was blocked by cycloheximide and the p62 protein level was followed in normoxia and hypoxia up to 4 h (Figure 4a ). Translational block had little effect on the normoxic p62 levels at short time points, whereas under hypoxia, the disappearance of p62 was strongly accelerated. This indicated that hypoxia causes accelerated post-translational clearance of p62. Two pathways that effectively clear proteins from cells are the UPS and the lysosome/autophagy system. To investigate whether the p62 clearance in response to hypoxia is mediated by the UPS, cells were exposed to hypoxia for 16 h followed by application of a proteosomal inhibitor MG-132 (10 mM) for 10 h. The inhibition of UPS activity stabilized HIF-1a in normoxia as expected. However, MG-132 neither led to normoxic accumulation of p62 nor did it prevent the disappearance of p62 in hypoxia (Figure 4a ). This indicated that p62 is not degraded by UPS during hypoxia.
p62 has been shown to be degraded by autophagy (Bjorkoy et al., 2005; Pankiv et al., 2007) . To study whether the hypoxic degradation of p62 is due to autophagy, cells were exposed to hypoxia for 16 h and subsequently treated with three different autophagy inhibitors for an additional 10 h (Figure 4b ). 3-Methyladenine (3-MA) blocks the activity of class III PI 3 kinase and inhibits the sequestration step during autophagy (Seglen and Gordon, 1982) ; bafilomycin A1 (Baf. A1) inhibits the vacuolar ATPase and blocks the fusion of autophagosomes with lysosomes (Yamamoto et al., 1998) . Erythro-9-[3-(2-hydroxynonyl)] adenine (EHNA) prevents the dynein-mediated transport of proteins through microtubules, thereby blocking autophagosome maturation (Ekstrom and Kanje, 1984) . None of the inhibitors had any marked effect on the normoxic p62 expression. However, Baf. A1 completely abolished the hypoxic degradation of p62. Furthermore, both 3-MA and erythro-9-[3-(2-hydroxynonyl)] adenine strongly attenuated the hypoxic degradation of p62 (Figure 4b ). Noticeably, neither 3-MA nor erythro-9-[3-(2-hydroxynonyl)] adenine had significant effect on the normoxic or hypoxic HIF-1a levels, whereas Baf. A1 stabilized HIF-1a in normoxia in agreement with a recent observation (Lim et al., 2006) .
The inhibition of p62 degradation by three diverse autophagy inhibitors strongly suggested the involvement of autophagy in the hypoxic degradation of p62. To further confirm the autophagy-mediated hypoxic degradation of p62, we used siRNA for LC3, an autophagosomal membrane protein (Kabeya et al., 2000) , to attenuate the autophagosome maturation. Cells were transfected with LC3 siRNA or nonspecific siRNA for 24 h followed by hypoxic exposure for an additional 24 h. In accordance with the results using the chemical autophagy inhibitors, LC3 siRNA effectively prevented the hypoxic downregulation of p62 (Figure 4c ). The data implied that the autophagymediated degradation of p62 is strongly enhanced in response to hypoxia.
Prompted by the different capacities of hypoxia and the inhibition of prolyl hydroxylase activity to induce downregulation of p62, we next investigated whether this was because of an unequal ability to activate autophagy. Two validated methods to measure autophagy activity were used. First, we analysed the processing of unmodified LC3-I to LC3-II that serves as a marker for active autophagy. HeLa cells were challenged with hypoxia or DMOG for 4-24 h, and LC3 processing was analysed by western blotting. Hypoxia increased the levels of endogenous LC3-II already at the 8-h time point and the amount of the processed LC3 gradually increased up to 24 h (Figure 5a ). Noticeably, DMOG was strikingly a less-efficient activator of autophagy as compared with hypoxia at these time points (Figure 5b ). Performed in parallel, the attenuation of HPH expression also failed to activate autophagy (data not shown).
To further study the hypoxic regulation of autophagy, HeLa cells were transiently transfected with vectors encoding enhanced green fluorescent protein (EGFP) or an EGFP-LC3 fusion protein. EGFP-LC3 is localized to autophagic vacuoles and shows punctuated expression upon activation of autophagy. EGFP was expressed evenly through out the cells regardless of O 2 concentration or DMOG. Consistent with the increased processing of LC3, EGFP-LC3 demonstrated an extensive accumulation of LC3-positive vesicles in hypoxia. However, in response to DMOG, significantly less EGFP-LC3-containing vesicles were detected ( Figures  5c and d) . This was in accordance with the hypoxic clearance of p62 by autophagy that is not mimicked by the inhibition of prolyl hydroxylase activity at 24 h. p62 participates in the regulation of hypoxia-induced ERK phosphorylation In p62 null mice, the sustained signal transduction through the Ras/ERK mitogenic pathway is increased and oxygen consumption is decreased (Rodriguez et al., 2006) . Furthermore, several lines of data indicate that hypoxia elevates Ras/ERK signalling (Minet et al., 2000; Kwon et al., 2006) . Motivated by this, we asked whether the hypoxia-mediated regulation of p62 has a role in controlling Ras/ERK signalling. HeLa cells were exposed to normoxia and hypoxia for 24 or 48 h followed by an analysis of phosphorylated ERK. The p62 expression was decreased by hypoxia as expected and, concomitantly, the phosphorylated ERK-1/2 (P-ERK-1/2) was increased by hypoxia. The total ERK-2 expression remained constant between the treatments (Figure 6a) . Next, the effect of p62 attenuation on phosphorylated ERK-1/2 was studied by using p62-specific siRNA. Cells treated with control siRNA demonstrated a strong decrease in p62 expression by hypoxia and a simultaneous increase in the P-ERK-1/2 levels. In contrast, the application of p62 siRNA resulted in an enhancement of ERK-1/2 phosphorylation, indicating a regulatory link between p62 and Ras/ERK signalling (Figure 6b ). On the basis of the simultaneous change in p62 downregulation and the appearance of phosphorylated ERK-1/2 during hypoxia as well as the previous report on the effect of p62 on ERK-1/2 phosphorylation (Rodriguez et al., 2006) , we argued that the increase in hypoxic ERK-1/2 phosphorylation is at least partly due to the reduced p62 expression. To study this, we used forced expression of a myc-tagged p62 (myc-p62wt) in hypoxic HeLa cells.
Twenty-four hours post-transfection, the cells were transferred to hypoxia for an additional 24 h. When compared with mock transfection, the forced expression of myc-p62wt reversed the hypoxia-induced increase in Figure 5 Effect of hypoxia and hydroxylase inhibition on the activation of autophagy. HeLa cells were exposed to (a) hypoxia or (b) DMOG (500 mM) for the indicated times. The modification of LC3-I to LC3-III, indicating autophagic activity, was studied by western blot analysis. The positions of LC3-I and LC3-II are indicated. HIF-1a was used to monitor hypoxia and hydroxylase inhibition. (c) HeLa cells transfected with EGFP or EGFP-LC3 and exposed to normoxia, hypoxia or DMOG (500 mM) for 24 h followed by visualization using fluorescence microscopy. (d) The percentage of cells exhibiting punctuated EGFP-LC3 fluorescence was calculated relative to all EGFP-positive cells. DMOG, dimethyloxaloylglycine; EGFP, enhanced green fluorescent protein; HIF, hypoxiainducible factor; LC3, light-chain 3.
ERK phosphorylation and P-ERK-1/2 was reduced back to the normoxic basal level (Figures 6c and d) . The data implied that the hypoxic attenuation of p62 expression allows the phosphorylation of ERK.
Discussion
Here we have shown that oxygen availability regulates the level of p62 protein. In response to hypoxia, p62 protein levels were reduced and the expression was restored in response to reoxygenation. The hypoxic downregulation of p62 was independent of HIFactivated transcription and was not mediated by proteasomal degradation. In contrast, both chemical and genetic inhibition of autophagy demonstrated that the hypoxic attenuation of p62 expression is due to autophagy-induced clearance. Three chemicals (3-MA, Baf. A1 and erythro-9-[3-(2-hydroxynonyl)] adenine), routinely used to inhibit autophagy at different stages of the autophagosome maturation, blocked the hypoxic reduction in p62 protein levels. Importantly, besides the chemical autophagy inhibitors, knockdown of the autophagosome membrane protein Atg8/LC3 by siRNA attenuated the hypoxia-induced degradation of p62, demonstrating that hypoxia dramatically accelerates the autophagosomal clearance of p62. To our knowledge, p62 is the first protein shown to be degraded through autophagy in response to a lowered oxygen availability.
Recent studies have indicated that hypoxia induces autophagy (Tracy et al., 2007; Zhang et al., 2008) . The vast majority of hypoxia-induced cellular responses are regulated by the HIF pathway. However, our data indicated that acute hypoxia (o24 h) can activate autophagy and autophagy-induced degradation of p62 in an HIF-independent manner. First, the hypoxic downregulation of p62 was not mimicked by a 24-h inactivation of prolyl hydroxylase activity with DMOG or DFO in HeLa cells. The 24-h exposure of the inhibitors also failed to activate autophagy. Accordingly, attenuation of the HPH expression by siRNA failed to activate p62 degradation. In keeping with this, stabilization of HIF expression by proteasomal inhibition did not affect p62 expression. Second, hypoxia did not induce changes in p62 mRNA level, suggesting a non-transcriptional response. This was supported by the finding that p62 is efficiently removed in response to hypoxia when HIF-1a and -2a expression is attenuated by siRNA. Finally, not only pVHL-deficient renal carcinoma cells that constitutively express HIF-a but also cells with reconstituted pVHL expression and normal HIF-a regulation demonstrated a similar hypoxic p62 degradation. Taken together, this indicated that the hypoxic downregulation of p62 in cancer cells was neither due to HIF-mediated transcriptional response nor due to VHL-mediated protein degradation.
At first sight, our results might seem contradictory to the recent report by Zhang et al. (2008) showing that hypoxia activates autophagy in an HIF-dependent manner through transcriptional activation of BNIP3. Noticeably, however, these studies were performed using mouse embryo fibroblasts. In accordance with this, we did not detect any effect of hypoxia on the p62 expression in mouse 3T3 fibroblasts (data not shown). Second, we detected autophagosomal p62 degradation upon prolonged inhibition of prolyl hydroxylase activity. This was observed with both DMOG and DFO after a 48-h exposure (Figure 2 ). Thus, hypoxia may activate autophagy in a biphasic manner. We argue that acute hypoxia may activate autophagosomal clearance of a defined set of proteins, such as p62, in an HIF-and prolyl hydroxylase-independent manner. Upon prolonged hypoxia, the HIF pathway would be engaged in the process causing a more widespread autophagy response through HIF-dependent transcription. Moreover, it is tempting to speculate that cancer cells have adapted an HIFindependent pathway to activate autophagy that would allow fast regulation of protein levels in response to cycles of hypoxia-reoxygenation in tumours.
Variable functions have been assigned for p62 depending on the cell type and experimental setting. The functions of p62 in malignant cells and during cancer progression are not completely understood, but a recent study indicates that in adenocarcinomas p62 expression is increased in response to oncogenic Ras activation and that this may promote survival (Duran et al., 2008) . However, during hypoxia, the downregulation of p62 may be required to adjust cellular energy metabolism to meet the diminished oxygen availability. This insight is supported by studies using p62 null mice, where the loss of p62 led to a constitutive upregulation of ERK phosphorylation and subsequently to an altered expression of various genes involved in energy metabolism. The outcome of the metabolic reprogramming was a decrease in energy expenditure, as determined by diminished oxygen consumption (Rodriguez et al., 2006) . In addition to the decreased energy and oxygen consumption, downregulation of p62 may also turn the cellular carbon flux to favour glycolysis, instead of oxidative phosphorylation. Moreover, the increased Ras/ERK activity by lowered p62 may induce cell survival and proliferation commonly seen in cancer cells. In keeping with this, accompanied with the hypoxic p62 degradation, ERK-1/2 was activated. Forced expression of p62 in hypoxia blocked the hypoxic activation of ERK phosphorylation, implying that the hypoxic downregulation of p62 was required to release the hypoxia-induced ERK phosphorylation.
Autophagy is thought to be involved in maintaining sufficient ATP levels during periods of energy limitations and to ensure the functionality of vital cellular processes such as transcription and protein synthesis under limited oxygen availability. Under hypoxia, autophagy decreases the amount of active mitochondria, thereby reducing both oxygen consumption and the production of reactive oxygen species (Zhang et al., 2008) , which is activated in cancer cells. In line with this, autophagy is activated in cancer cells where it enhances cell survival during later stages of cancer development, concomitantly with an increase in hypoxic tumour regions. Our data show that the hypoxic autophagy is accompanied by p62 downregulation and elevated Ras/ ERK signalling, suggesting that the hypoxic clearance of p62 by autophagy has an essential role in the protection of cancer cells against hypoxic stress. 0 -CGUACGCUCUUUACAGAUA(dTdT)-3 0 . Plasmids used (pDestmyc-p62 and pEGFP-LC3) have been described in detail elsewhere (Lamark et al., 2003; Bjorkoy et al., 2005) .
Materials and methods
Dimethyloxaloylglycine (Cayman Chemical, Ann Arbor, MI, USA), DFO (Sigma-Aldrich), 3-MA (Sigma-Aldrich), Baf. A1 (LC Laboratories, Woburn, MA, USA), erythro-9-[3-(2-hydroxynonyl)] (Sigma-Aldrich) and MG-132 (Calbiochem, San Diego, CA, USA) were used at the indicated concentrations.
Detection of proteins
For protein analysis, cells were harvested in SDS-Triton lysis buffer (50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 10 mM NaF, 0.5% Triton X-100, 1% SDS, 1 mM Na 3 VO 4 , 1mM phenylmethylsulphonyl fluoride and complete protease inhibitors) followed by the addition of 2-mercaptoethanol, sonication and boiling before loading or urea lysis buffer ( Supplementary  Figure 1) , where SDS-Triton was replaced with 9 M urea. Protein concentrations were measured with Bio-Rad DC protein assay before addition of mercaptoethanol or boiling, and equal amounts of protein were loaded and run on SDS-PAGE in a mini-gel chamber (Bio-Rad, Hercules, CA, USA) and transferred to a PVDF membrane (Millipore, Billerica, MA, USA). Western blot analyses with the following antibodies were performed with indicated dilutions: guinea-pig polyclonal p62 (Progen Biotechnik, Heidelberg, Germany) at 1:5000, mouse monoclonal Hif-1a (BD Transduction Laboratories, San Jose, CA, USA) at 1:1500, mouse monoclonal P-ERK-1/2 (Santa Cruz Biotechnology, catalogue no. sc-7383) at 1:4000, goat polyclonal ERK-2 (Santa Cruz Biotechnology, catalogue no. sc-154-G) 1:4000 and mouse monoclonal AC-40 actin antibody (Sigma-Aldrich) at 1:5000 dilution, rabbit polyclonal anti-LC3 (Novus Biologicals, Littleton, CO, USA) at 1:1500, mouse antiGolgin-97 at 1:200 (Molecular Probes, Eugene, OR, USA) and mouse monoclonal anti-Myc (Sigma) at 1:1500. All primary antibody incubations were performed over night at þ 41C followed by secondary antibody treatment for 1 h at room temperature. Anti-mouse HRP, anti-rabbit HRP (DAKO, Carpinteria, CA, USA) and anti-guinea-pig HRP (Sigma) antibodies were used at 1:5000 dilutions. Proteins were detected with enhanced chemiluminescence reagent (Amersham, Piscataway, NJ, USA). For quantifying protein expression and phosphorylation levels, open source image analysis software (ImageJ, NIH, http://rsb.info.nih.gov/ij/) was used.
For fluorescence microscopy, cells were grown on coverslips and fixed with PTEMF buffer containing 4% formaldehyde (PTEMF buffer: 4% formaldehyde, 10 mM EGTA, 1 mM MgCl 2 , 20mM PIPES (pH 6.8) and 0.2% TX-100). The guinea-pig anti-p62 antibody was used at 1:2000 dilution. Alexa Fluor-555-labelled goat anti-guinea-pig antibody (Invitrogen) was used as secondary antibody. Cells were visualized with LSM 510 confocal microscope (Zeiss).
